Prescription Drug Abuse Part 3 – – San Diego – Judy Saalinger


Prescription Drug Abuse Part 3 – – San Diego – Judy Saalinger – Visit or call 858-453-4315 to find the help you need. Part 1 of a 3-part Audio Program focusing on MARIJUANA: Is It Addicting?, with Dr. Judy Saalinger of Lasting Recovery, the premiere San Diego outpatient treatment center. Judy Saalinger, Ph.D., MFT, CAS, and Arthur Farkas, Ph.D., founded Lasting Recovery in July, 2004. With well over 30 years of therapeutic and clinical work in the field and many years of personal recovery from addictions, the husband and wife team recognized an opportunity for their work to have an even greater impact while addressing the unmet need for quality outpatient addiction treatment in San Diego. Lasting Recovery’s History: •July 2004 – Opened the doors to Lasting Recovery for Outpatient Treatment •January 2005 –Certified by California Alcohol and Drug Programs •January 2010 — Awarded CARF Accreditation •May 2010 –TRICARE Certified Substance Use Disorder Rehab Facility (SUDRF) We work with individuals and families and offer hope for a healing recovery and a promising future. We coordinate care with psychiatrists, therapists, psychologists, family and primary care physicians, facilities, attorneys, employers, universities and diversion boards through confidential, professional assistance with education, referrals, and placement services. We refer to: •Interventionists •Inpatient detoxification and treatment facilities •Transitional/ sober living homes •Psychiatrists •Psychotherapists •Primary care physicians Lasting


Halozyme Reports Third Quarter 2012 Financial Results

Filed under: drug treatment programs in san diego

"With potential launches and near-term revenue streams from both subcutaneous Herceptin and MabThera, we are increasing our manufacturing activities to build launch inventory of the rHuPH20 enzyme in support of these programs. We also … Announced …
Read more on Sacramento Bee


Santarus and Pharming announce positive Top-Line Phase III results for

Filed under: drug treatment programs in san diego

SAN DIEGO and LEIDEN, The Netherlands (November 7, 2012) – Santarus, Inc. (NASDAQ: SNTS) and Pharming Group NV (NYSE Euronext: PHARM) today announced that their pivotal Phase III clinical study to evaluate the safety and efficacy of the investigational …
Read more on Reuters